Clinical Trial Search

Primary: The Aim of This Study is to Determine the Effect of Fluticasone/Salmeterol on Sleep Quality in Patients With COPD and to Compare Efficacy of Advair 250 Compared to…

Primary: Mean Change in Product of BSA (Body Surface Affected by Psoriasis) and sPGA (Static Physician Global Assessment) From Baseline to Week 16 — -9 score on a scale

Primary: Change From Baseline in Glycosylated Haemoglobin A1c (HbA1c) After 16 Weeks of Treatment. — 0.00; -0.92; -1.00 percentage of HbA1c — p=<0.0001

Primary: Change in Haemoglobin A1c (HbA1c) From Baseline to Week 52 — -0.82; -1.2; -0.99 HbA1c % — p=0.001

Primary: Number of Participants Without Respiratory Reaction During Aspirin Desensitization — 0; 5 Participants — p=0.036

Primary: Number of Participants With Adverse Drug Reactions (e.g., Allergic Reactions, TEs, TEEs (Thromboembolic Events) and Hyperfibrinolytic Events) — 5; 0; 0; 0 participants

Primary: Mean of the Absolute Values of CSRT Difference Month 3 to Month 6 — 25.16; 29.28 micrometers — p=0.1850

Primary: Acetazolamide Arm: Natriuresis 24 h — 324; 300; 211; 190 mmol — p=0.515

Primary: Change From Baseline in Trough Pre-dose FEV1 in Both Arms — 0.036; -0.009 Liters — p=0.028

Primary: Serum Anti-HBs Concentration 12 IU/L or Greater — 30; 76 Participants

Primary: Change in VAS Pain Scores — 3.0; 3.0; 2.7; 3.9 scores on a scale

Primary: Investigator Global Assessment (IGA) Score — 0; 0; 20; 0 Participants

Primary: The Incidence of New Onset of Diabetes After Transplant (NODAT) 12 Months After Kidney Transplantation — 3; 1 Participants — p=0.87

Primary: Percentage of Nail Polish Disruption Using the Likert Scale — 0.6; 0 percentage of nail polish disruption

Primary: Trough FEV1 at Week 12 for Group: Glycopyrronium vs. Short-acting Bronchodilators (SABA and/or SAMA as Monotherapy or in Free or FDC) — 1.8264; 1.8916 Liters — p=0.0180